Global Celiac Disease Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Celiac Disease Market Analysis

Celiac disease is an autoimmune illness in which a protein called gluten damages the small intestine's membrane. Gluten can be present in grains such as rye, barley, and wheat. Gluten causes an immunological reaction that damages the villi in the small intestine (small finger-like projections in the small intestine which promote absorption). The body's ability to absorb proteins, nutrients, lipids, vitamins, carbs, and minerals is hampered by the damage. This eventually leads to malnutrition.

Celiac Disease Market Size

Global celiac disease market size was valued at USD 968.81 million in 2024 and is projected to reach USD 2137.92 million by 2032, with a CAGR of 10.4% during the forecast period of 2025 to 2032.

Report Scope and Market Segmentation       

Celiac Disease Market Definition

Celiac disease, also known as the celiac sprue or gluten-sensitive enteropathy. It is an immune reaction to eating gluten, a protein found in barley, wheat and rye. Eating gluten triggers an immune response in one’s small intestine.

Celiac Disease Market Dynamics

Drivers

• Rise in the incidence of celiac disease population

Due to the growing celiac disease population, there is a rise in the demand in the application of gluten-free products which acts as one of the major factors driving the growth of celiac disease market.

• Increase in the investment in research and development

Robust research and development activities are bringing newer treatment options which is one of the major contributor to the market growth.

• Growing awareness regarding the celiac disease

Rising awareness related to the disease because consumption of gluten is further anticipated to propel to the market growth.

Opportunities

In addition, the growing initiatives by the government will further provide potential opportunities for the growth of the celiac disease market in the coming years.

Restraints/Challenges

On the other hand, the decrease in the number of effective treatment is further projected to impede the growth in the celiac disease market in the timeline period. However, the increased cost involved in research might further challenge the growth of the celiac disease market in the near future.

This celiac disease market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on celiac disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Celiac Disease Market Scope

The celiac disease market is segmented on the basis of treatment, type, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Infliximab
• Larazotide Acetate
• Gluten Free Diet
• Others

Route of Administration

• Oral
• Parenteral

End Users

• Hospitals
• homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Celiac Disease Market Regional Analysis

The celiac disease market is analysed and market size insights and trends are provided by country, treatment, type, route of administration, end users and distribution channel as referenced above.

The countries covered in the celiac disease market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America dominates the celiac disease market due to the rise in the refined healthcare expenses. Furthermore, the increase in the patient awareness level growing incidence of celiac diseases will further boost the growth of the celiac disease market in the region during the forecast period.

Europe is projected to observe significant amount of growth in the celiac disease market due to the occurrence of global market players. Moreover, the rising government support for vaccine development is further anticipated to propel the growth of the celiac disease market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Celiac Disease Market Share

The celiac disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to celiac disease market.

Celiac Disease Market Leaders Operating in the Market Are:

• Innovate Biopharmaceuticals (US)
• Teva Pharmaceutical Industries Ltd (Israel)
• ImmunogenX, LLC (US)
• Amgen (US)
• ChemoCentryx, Inc (US)
• Anokion SA (Switzerland)
• COUR Pharmaceutical (US)
• F. Hoffmann-La Roche Ltd (Switzerland)
• BioLineRx Ltd (Israel)
• Takeda Pharmaceutical Company Limited (Japan)

SKU-53037